Saul Centers, Inc. – Consensus Indicates Potential 17.9% Upside

DirectorsTalk Interviews

Saul Centers, Inc. found using ticker (BFS) now have 3 analysts in total covering the stock. The consensus rating is ‘Hold’. The target price ranges between 53 and 50 calculating the average target price we see 51. Now with the previous closing price of 43.24 this is indicating there is a potential upside of 17.9%. The 50 day MA is 48.01 and the 200 day moving average is 49.21. The company has a market capitalisation of $1,418m. You can visit the company’s website by visiting: https://www.saulcenters.com

The potential market cap would be $1,673m based on the market concensus.

Saul Centers, Inc. is a self-managed, self-administered equity REIT headquartered in Bethesda, Maryland, which currently operates and manages a real estate portfolio of 60 properties which includes (a) 50 community and neighborhood shopping centers and seven mixed-use properties with approximately 9.8 million square feet of leasable area and (b) three land and development properties. Approximately 85% of the Saul Centers’ property operating income is generated by properties in the metropolitan Washington, DC/Baltimore area.

Share on:
Find more news, interviews, share price & company profile here for:

    Boku partners with Canva to boost access in Asia and Europe via localised payments

    Boku has announced a strategic partnership with Canva to expand the design platform’s reach across Asia and Europe through localised payment methods. The collaboration has already launched Vietnam’s MoMo digital wallet on Canva, with more integrations planned for 2025, aiming to make the platform more accessible in regions where card usage is low.

    Jubilee Metals to sell SA chrome and PGM assets for US$90m

    Jubilee Metals has issued a circular outlining plans to sell its Chrome and PGM Operations in South Africa to One Chrome (Pty) Ltd for up to US$90 million.

    Real Estate Credit Investments posts 2025 AGM circular

    Real Estate Credit Investments has issued its 2025 AGM circular and proxy form to shareholders. The meeting will take place on 17 September 2025 at East Wing, Trafalgar Court, St. Peter Port, Guernsey, with documents available via the National Storage Mechanism.

    Nuformix applies for US Orphan Drug Designation for NXP002 in IPF

    Nuformix has submitted an application to the US FDA for Orphan Drug Designation for tranilast, the active ingredient in its NXP002 inhaled therapy for idiopathic pulmonary fibrosis.

    Dekel Agri-Vision sees record cashew output, higher palm oil prices

    Dekel Agri-Vision has announced a July 2025 update, highlighting record monthly raw cashew nut processing of 533 tonnes at its Tiebissou plant, up 423% from July 2024.

    Diversified Energy delivers strong H1 2025 with Carlyle partnership boost

    Diversified Energy Company posted first-half 2025 results in line with expectations, delivering strong production growth, improved financial metrics, and $152 million in adjusted free cash flow

      Search

      Search